NAT-EVEROLIMUS
Analogs of NAT-EVEROLIMUS
Find cheaper analogs and generic equivalents for NAT-EVEROLIMUS.
Active Ingredient: EVEROLIMUS
Product Overview
About NAT-EVEROLIMUS
NAT-EVEROLIMUS is a prescription medication containing the active ingredient Everolimus, an inhibitor of the mammalian target of rapamycin (mTOR). It is used to treat various conditions, including certain types of cancer and transplant-related complications.
Key Benefits & Uses
- Treatment of renal cell carcinoma (RCC) after failure of tyrosine kinase inhibitors (TKIs)
- Treatment of neuroendocrine tumors (NETs) of pancreatic origin
- Prevention of organ rejection in kidney transplant patients
- Treatment of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC)
Active Ingredient & Action
Everolimus works by inhibiting the mTOR pathway, which regulates cell growth and proliferation. By blocking this pathway, Everolimus can help slow or stop the growth of cancer cells and prevent organ rejection in transplant patients.
Important Notes
NAT-EVEROLIMUS is available in capsule form and should be taken orally as directed by a healthcare professional. It is essential to follow the recommended dosage and schedule to minimize the risk of side effects. Patients should also inform their doctor about any medical history, allergies, or current medications before starting treatment with NAT-EVEROLIMUS.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.